Fact CheckerSign in

NCT06934356Recruiting

Subcortical Arousal in Perceptual Awareness

Shared Subcortical Arousal Systems Across Perceptual Modalities

Source: ClinicalTrials.gov · Last updated 10 Aug 2026

Brief summary (registry, in English)

The study consists of prospective enrollment of healthy participants and patients with epilepsy, as well as analysis of an existing data set. Healthy participants will be studied with fMRI, eye metrics and behavioral testing at Yale. Patients will be studied with intracranial thalamic and cortical recording and stimulation, eye metrics and behavioral testing.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
202 (estimated)
First submitted
19 Mar 2025
Start date
13 Oct 2025
Primary completion date
Dec 2030
Lead sponsor
Yale University
Diseases
Epilepsy
NCT number
NCT06934356

What you commit to

  • Study type: Interventional
  • Planned participants: 202
  • From 13 Oct 2025 to the primary completion date, Dec 2030
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • The following are the inclusion/exclusion criteria for healthy participants age 18 years and up (Aim 1 and 2):
    • Inclusion: (1) normal vision with or without the use of corrective lenses; (2) normal hearing not needing an assistive hearing device.
    • Exclusion: (1) past history of diagnosis of a psychiatric or neurologic disease; (2) current psychiatric or neurologic disease; (3) requires hard contact lenses or glasses to maintain normal vision (prevents accurate pupil and eye gaze measurements); (4) pregnant or nonremovable ferrous metal objects inside or on the body (prevents MRI).
  • The following are the inclusion/exclusion criteria for epilepsy patients with thalamic electrodes age 13 years and up (Aim 3A):
    • Inclusion: (1) normal vision with or without the use of corrective lenses
    • Exclusion: (1) severe vision impairment even with correction preventing ability to see stimuli (prevents accurate pupil and eye gaze measurements); (2) unable to perform the perception task due to cognitive impairment. All participants must be capable of consenting for themselves.
  • The following are the inclusion/exclusion criteria for epilepsy patients with thalamic electrodes age 18 year and up (Aim 3B):
    • Inclusion: (1) normal vision with or without the use of corrective lenses; (2) A female subject must have a negative pregnancy test and if sexually active, must be using a reliable form of birth control for the duration of the trial, be surgically sterile, or be at least two years post-menopausal.
    • Exclusion: (1) severe vision impairment even with correction preventing ability to see stimuli (prevents accurate pupil and eye gaze measurements); (2) unable to perform the perception task due to cognitive impairment. All participants must be capable of consenting for themselves; (3) Pregnancy.

Age in the registry: 13 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Baylor College of Medicine
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting
University of Kansas Medical Center
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting
Dartmouth Hitchcock Medical Center
Coordinator of this site? Confirm its status
LebanonUnited StatesRecruiting
Vanderbilt University Medical Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesRecruiting
Yale School of Medicine
Coordinator of this site? Confirm its status
New HavenUnited StatesRecruiting
University of Pittsburgh Medical Center
Coordinator of this site? Confirm its status
PittsburghUnited StatesNot yet recruiting
Mayo Clinic
Coordinator of this site? Confirm its status
RochesterUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.